Clinical Trial

VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up (VITAL)

Study acronym: VITAL
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 4, 2023 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is an observational study to evaluate the long-term safety and effectiveness of the valve system.
Trial Details
NCT Number NCT05977257
Lead Sponsor Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Conditions Aortic Valve Disease, Aortic Valve Stenosis
Enrollment 89 participants
Start Date 2023-07-30
Primary Completion 2025-10-30 (estimated)
Study Completion 2028-10-30 (estimated)
Updated on ClinicalTrials.gov 2023-08-04